Literature DB >> 25951665

Venlafaxine inhibits apoptosis of hippocampal neurons by up-regulating brain-derived neurotrophic factor in a rat depression model.

Xiao Huang, Yue-Shi Mao, Chao Li, Hao Wang, Jian-Lin Ji.   

Abstract

The effect of venlafaxine on the expression of brain-derived neurotrophic factor (BDNF) in rat hippocampal neurons was studied, as well as its inhibitory effect on apoptosis of hippocampal neurons. Differences in behavioral ability between the depression model group and the venlafaxine treatment group were observed in behavioral, sucrose-water and open field tests. The rat hippocampal tissue was sliced, stained and observed for BDNF distribution by immunohistochemistry. Apoptosis of hippocampal neurons was detected by TUNEL. BDNF expression in the hippocampal tissue was detected by Western blot. Injury and apoptosis of the hippocampal tissue were observed by electron microscopy. Behavioral test showed that venlafaxine effectively improved the behavioral abilities of depressed rats. Immunohistochemistry showed that venlafaxine markedly increased BDNF expression in the rat hippocampus. TUNEL showed that venlafaxine markedly inhibited apoptosis of hippocampal neurons, which was also confirmed by electron microscopic observation of the pathologic sections. Venlafaxine improved the expression of BDNF by influencing the PI3k/PKB/eNOS pathway and repressed the apoptosis of hippocampal neurons.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25951665

Source DB:  PubMed          Journal:  Pharmazie        ISSN: 0031-7144            Impact factor:   1.267


  6 in total

1.  Venlafaxine Mitigates Depressive-Like Behavior in Ovariectomized Rats by Activating the EPO/EPOR/JAK2 Signaling Pathway and Increasing the Serum Estradiol Level.

Authors:  Muhammed A Saad; Ayman E El-Sahar; Rabab H Sayed; Eman M Elbaz; Hebatullah S Helmy; Mahmoud A Senousy
Journal:  Neurotherapeutics       Date:  2019-04       Impact factor: 7.620

2.  Increased serum levels of apoptosis in deficit syndrome schizophrenia patients: a preliminary study.

Authors:  Murat Beyazyüz; Tarkan Küfeciler; Leyla Bulut; Cüneyt Ünsal; Yakup Albayrak; Esra Soydaş Akyol; Saliha Baykal; Murat Kuloglu; Kenji Hashimoto
Journal:  Neuropsychiatr Dis Treat       Date:  2016-05-23       Impact factor: 2.570

Review 3.  The Role of Neural Plasticity in Depression: From Hippocampus to Prefrontal Cortex.

Authors:  Wei Liu; Tongtong Ge; Yashu Leng; Zhenxiang Pan; Jie Fan; Wei Yang; Ranji Cui
Journal:  Neural Plast       Date:  2017-01-26       Impact factor: 3.599

Review 4.  Changes in Hippocampal Plasticity in Depression and Therapeutic Approaches Influencing These Changes.

Authors:  Wenbo Xu; Xiaoxiao Yao; Fangyi Zhao; Haisheng Zhao; Ziqian Cheng; Wei Yang; Ranji Cui; Songbai Xu; Bingjin Li
Journal:  Neural Plast       Date:  2020-11-26       Impact factor: 3.599

5.  Vitamin B1 and B12 mitigates neuron apoptosis in cerebral palsy by augmenting BDNF expression through MALAT1/miR-1 axis.

Authors:  En-Yao Li; Peng-Ju Zhao; Jie Jian; Bao-Qi Yin; Zhen-Yu Sun; Cui-Xiang Xu; You-Cai Tang; Hong Wu
Journal:  Cell Cycle       Date:  2019-09-10       Impact factor: 4.534

6.  Therapeutic Targets and Mechanism of Xingpi Jieyu Decoction in Depression: A Network Pharmacology Study.

Authors:  Ze Chang; Li-Juan He; Dang-Feng Tian; Qiang Gao; Jing-Feng Ling; Yu-Chun Wang; Zhen-Yun Han; Rong-Juan Guo
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-23       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.